The Cost Effectiveness of Infliximab for Severe Treatment-Resistant Rheumatoid Arthritis in the UK
Year of publication: |
2005
|
---|---|
Authors: | Barbieri, Marco ; Wong, John B. ; Drummond, Michael |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 23.2005, 6, p. 607-618
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-utility | Disease-modifying-antirheumatics | Infliximab | Methotrexate | Rheumatoid-arthritis | Tumour-necrosis-factor-antagonists |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Nguyen, Christine M., (2012)
-
(2012)
-
Bounthavong, Mark, (2012)
- More ...
-
Stoykova, Boyka, (2003)
-
The lag between effectiveness and cost-effectiveness evidence of new drugs
Stoykova, Boyka, (2003)
-
Liem, Ylian S, (2010)
- More ...